Resmed (RMD) Raw Materials (2010 - 2026)

Resmed's Raw Materials history runs 17 years deep, the most recent figure standing at $350.9 million for Q1 2026.

• Quarterly Raw Materials rose 2.31% year-over-year to $350.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $350.9 million (up 2.31% YoY) and the FY2025 annual result came in at $367.3 million, up 3.29% from the prior year.
• Raw Materials was $350.9 million for Q1 2026 at Resmed, down from $374.7 million in the prior quarter.
• Across five years, Raw Materials topped out at $468.8 million in Q1 2023 and bottomed at $340.3 million in Q1 2022.
• A 5-year average of $392.9 million and a median of $373.3 million in 2024 frame the typical range for Raw Materials.
• Annual changes were most pronounced in 2022 — Raw Materials soared 134.0% — and 2024, when it dropped 22.56%.
• Resmed's Raw Materials stood at $463.4 million in 2022, then climbed by 0.82% to $467.2 million in 2023, then slipped by 21.92% to $364.8 million in 2024, then climbed by 2.72% to $374.7 million in 2025, then retreated by 6.36% to $350.9 million in 2026.
• Business Quant data shows RMD's Raw Materials at $350.9 million in Q1 2026, $374.7 million in Q4 2025, and $363.4 million in Q3 2025.